Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Falk

Showing results (391-400 of 635) with videos related to

Pageof 64
Sort By:
Zeitschrift Fur Gastroenterologie|March 7, 2008
NAT1 genotypes do not predict response to mesalamine in patients with ulcerative colitisM Hausmann, G Paul, K Menzel, et al.
Clinical and Experimental Immunology|February 1, 1997
Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in miceG Kojouharoff, W Hans, F Obermeier, et al.
Alimentary Pharmacology & Therapeutics|April 28, 2020
Editorial: fluticasone propionate orally disintegrating tablets-interesting concept but is it going anywhere? Authors' replyIkuo Hirano, Ekaterina Safroneeva, Marie C Roumet, et al.
Current Microbiology|March 17, 2004
Sequence analysis of DNA fragments from the genome of the primary endosymbiont of the whitefly Bemisia tabaciLinda Baumann, MyLo Ly Thao, C Joel Funk, et al.
Scandinavian Journal of Gastroenterology|May 5, 2001
Differential activation of cytokine secretion in primary human colonic fibroblast/myofibroblast culturesG Rogler, C M Gelbmann, D Vogl, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 1, 1994
p53 immunoreactivity in Barrett's metaplasia, dysplasia, and carcinomaT W Rice, J R Goldblum, G W Falk, et al.
Alimentary Pharmacology & Therapeutics|March 10, 2020
Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitisIkuo Hirano, Ekaterina Safroneeva, Marie C Roumet, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 12, 2020
Type II achalasia is associated with a comparably favorable outcome following per oral endoscopic myotomyYutaka Tomizawa, Nadim Mahmud, Kevin Dasher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
Suppression of cytotoxic T lymphocyte activation by L-ornithineW Dröge, D Männel, W Falk, et al.
European Cytokine Network|March 1, 1990
Autocrine growth factors secreted by the malignant human B-cell-line BJAB are distinct from other known cytokinesH Lahm, J R Fischer, Y Reichert, et al.
Pageof 64

Showing results (391-400 of 635) with videos related to

Sort By:
Pageof 64
Zeitschrift Fur Gastroenterologie|March 7, 2008
NAT1 genotypes do not predict response to mesalamine in patients with ulcerative colitisM Hausmann, G Paul, K Menzel, et al.
Clinical and Experimental Immunology|February 1, 1997
Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in miceG Kojouharoff, W Hans, F Obermeier, et al.
Alimentary Pharmacology & Therapeutics|April 28, 2020
Editorial: fluticasone propionate orally disintegrating tablets-interesting concept but is it going anywhere? Authors' replyIkuo Hirano, Ekaterina Safroneeva, Marie C Roumet, et al.
Current Microbiology|March 17, 2004
Sequence analysis of DNA fragments from the genome of the primary endosymbiont of the whitefly Bemisia tabaciLinda Baumann, MyLo Ly Thao, C Joel Funk, et al.
Scandinavian Journal of Gastroenterology|May 5, 2001
Differential activation of cytokine secretion in primary human colonic fibroblast/myofibroblast culturesG Rogler, C M Gelbmann, D Vogl, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 1, 1994
p53 immunoreactivity in Barrett's metaplasia, dysplasia, and carcinomaT W Rice, J R Goldblum, G W Falk, et al.
Alimentary Pharmacology & Therapeutics|March 10, 2020
Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitisIkuo Hirano, Ekaterina Safroneeva, Marie C Roumet, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 12, 2020
Type II achalasia is associated with a comparably favorable outcome following per oral endoscopic myotomyYutaka Tomizawa, Nadim Mahmud, Kevin Dasher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
Suppression of cytotoxic T lymphocyte activation by L-ornithineW Dröge, D Männel, W Falk, et al.
European Cytokine Network|March 1, 1990
Autocrine growth factors secreted by the malignant human B-cell-line BJAB are distinct from other known cytokinesH Lahm, J R Fischer, Y Reichert, et al.
Pageof 64